Montelukast Use Decreases Cardiovascular Events in Asthmatics

Montelukast Use Decreases Cardiovascular Events in Asthmatics

Cysteinyl leukotrienes are proinflammatory mediators with a clinically established role in asthma and a human genetic and preclinical role in cardiovascular pathology. Given that cardiovascular disease has a critical inflammatory component, the aim of this work was to conduct an observational study...

Full description

Bibliographic Details
Main Authors: Malvina Hoxha, Calogero C. Tedesco, Silvana Quaglin, Visar Malaj, Linda Pustina, Valerie Capra, Jilly F. Evans, Angelo Sala, G. Enrico Rovati
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Pharmacology
Subjects:
asthma
montelukast
inflammation
cardiovascular diseases
leukotriene receptors
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.611561/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.611561/full

Similar Items